iBio
IBIO
#10074
Rank
C$37.27 M
Marketcap
C$1.66
Share price
-6.25%
Change (1 day)
-54.35%
Change (1 year)

iBio (IBIO) - Cash on Hand

Cash on Hand as of June 2025 : C$11.85 Million

According to iBio's latest financial reports the company has C$11.85 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

iBio - Cash on Hand chart (from 2008 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-06-30C$19.42 M241.31%
2023-06-30C$5.69 M-86.81%
2022-06-30C$43.15 M-64.09%
2021-06-30C$0.12 B60.64%
2020-06-30C$74.81 M1192.67%
2019-06-30C$5.78 M-72.38%
2018-06-30C$20.95 M99.42%
2017-06-30C$10.5 M-64.77%
2016-06-30C$29.82 M151.75%
2015-06-30C$11.84 M209.21%
2014-06-30C$3.83 M-17.45%
2013-06-30C$4.64 M-18.96%
2012-06-30C$5.72 M108.96%
2011-06-30C$2.74 M184.47%
2010-06-30C$0.96 M-19.33%
2009-06-30C$1.19 M6068.03%
2008-06-30C$0.01 M-3.04%
2007-06-30C$0.01 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Genocea Biosciences
GNCA
C$27.81 M 134.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.33 B 2,760.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$25.64 B 216,189.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
C$0.37 B 3,048.54%๐Ÿ‡บ๐Ÿ‡ธ USA